| scholarly article | Q13442814 |
| P2093 | author name string | Kathleen M Morrow | |
| Monica S Ruiz | |||
| P2860 | cites work | Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going? | Q34194652 |
| Microbicide acceptability research: current approaches and future directions | Q35937340 | ||
| Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050). | Q40174753 | ||
| Perspectives related to the potential use of vaginal microbicides among drug-involved women: focus groups in three cities in the United States and Puerto Rico | Q40539748 | ||
| The Acceptability of an Investigational Vaginal Microbicide, PRO 2000 Gel, among Women in a Phase I Clinical Trial | Q43987534 | ||
| Microbicides--evaluating multiple formulations of C31G. | Q44223709 | ||
| Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery. | Q51170392 | ||
| Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women. | Q51203988 | ||
| Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen. | Q51418757 | ||
| A framework for examining the sustained acceptability of microbicides. | Q51509638 | ||
| In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse. | Q51582253 | ||
| Gravity-induced coating flows of vaginal gel formulations: in vitro experimental analysis. | Q51605802 | ||
| Preaching to the choir: preference for female-controlled methods of HIV and sexually transmitted disease prevention | Q74009430 | ||
| Acceptability of a novel vaginal microbicide during a safety trial among low-risk women | Q74171649 | ||
| Integrating behavioral and social science research into microbicide clinical trials: challenges and opportunities | Q81551081 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 272-283 | |
| P577 | publication date | 2007-06-26 | |
| P1433 | published in | AIDS and Behavior | Q15752229 |
| P1476 | title | Assessing microbicide acceptability: a comprehensive and integrated approach. | |
| P478 | volume | 12 |
| Q35736962 | "Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study |
| Q50135709 | Acceptability and Preferences for Hypothetical Rectal Microbicides among a Community Sample of Young Men Who Have Sex with Men and Transgender Women in Thailand: A Discrete Choice Experiment. |
| Q33631838 | Acceptability in microbicide and PrEP trials: current status and a reconceptualization |
| Q34018830 | Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand |
| Q33833859 | Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men. |
| Q33584769 | Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study |
| Q51358110 | Acceptability of coitally-associated versus daily use of 1% tenofovir vaginal gel among women in Pune, India. |
| Q41692597 | Aligning product development and user perspectives: social-behavioural dimensions of multipurpose prevention technologies |
| Q34462922 | An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana |
| Q37019725 | Australian men's experiences during a microbicide male tolerance study |
| Q34645034 | Clinical evaluation of microbicide formulations |
| Q27005602 | Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches |
| Q36276130 | Designing a multipurpose technology for acceptability and adherence |
| Q53751650 | Designing and developing suppository formulations for anti-HIV drug delivery. |
| Q37597118 | Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties |
| Q64137772 | Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques |
| Q36111516 | Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1 |
| Q37520083 | First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics |
| Q36034691 | Hypothetical Rectal Microbicide Acceptability and Factors Influencing It among Men Who Have Sex with Men in Tianjin, China |
| Q33761194 | Increasing the effectiveness of vaginal microbicides: a biophysical framework to rethink behavioral acceptability |
| Q36331527 | Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings |
| Q37707803 | Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides. |
| Q30399805 | Muslim women's reflections on the acceptability of vaginal microbicidal products to prevent HIV infection |
| Q35563416 | Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc. |
| Q39356290 | On-demand microbicide products: design matters |
| Q38661098 | Patterns of a Rectal Microbicide Placebo Gel Use in a Preparatory Stage for a Phase I Trial Among Young Men Who Have Sex with Men. |
| Q42668432 | Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design |
| Q37657468 | Pharmaceutical development of microbicide drug products |
| Q37159238 | Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. |
| Q36425572 | Quantitative perceptual differences among over-the-counter vaginal products using a standardized methodology: implications for microbicide development |
| Q35012572 | Rectal microbicides: can we make them and will people use them? |
| Q37336226 | Research on adolescents and microbicides: a review. |
| Q38829870 | Secrecy, empowerment and protection: positioning PrEP in KwaZulu-Natal, South Africa |
| Q30538073 | Shape of vaginal suppositories affects willingness-to-try and preference |
| Q37157173 | Spray drying tenofovir loaded mucoadhesive and pH-sensitive microspheres intended for HIV prevention. |
| Q35822713 | The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention. |
| Q37088184 | To Use a Rectal Microbicide, First Insert the Applicator: Gel and Applicator Satisfaction Among Young Men Who Have Sex With Men. |
| Q37765518 | Toward an information-motivation-behavioral skills model of microbicide adherence in clinical trials |
| Q54943162 | User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences. |
| Q40156813 | User input in iterative design for prevention product development: leveraging interdisciplinary methods to optimize effectiveness |
| Q27318051 | User preferences in a carrageenan-based vaginal drug delivery system |
| Q35082722 | User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides. |
| Q36126061 | Using integrated mixed methods to develop behavioral measures of factors associated with microbicide acceptability |
| Q35691650 | Variations in microbicide gel acceptability among young women in the USA and Puerto Rico |
Search more.